Thoracic Complications of Illicit Drug Use: An Organ System Approach

Authors:
  • SMShelley R. Marder
    Shelley R. Marder
  • DHDouglas K. Hanks
    Douglas K. Hanks
  • JLJessica W. T. Leung
    Jessica W. T. Leung
  • SDSamuel K. Dawn
    Samuel K. Dawn
  • AGAlisa D. Gean
    Alisa D. Gean
  • GRGautham P. Reddy
    Gautham P. Reddy
  • PAPhilip A. Araoz
    Philip A. Araoz
  • WWW. Richard Webb
    W. Richard Webb
Publisher website
Google Scholar
Abstract
Illicit drug use constitutes a major health problem and may be associated with various thoracic complications. These complications vary depending on the specific drug used and the route of administration. Commonly abused drugs that may play a role in causing thoracic disease include cocaine, opiates, and methamphetamine derivatives. Intravenously abused oral medications may contain filler agents that may be responsible for disease. Thoracic complications may be categorized as pulmonary, pleural, mediastinal, cardiovascular, and chest wall complications. Pulmonary complications of drug abuse include pneumonia, cardiogenic edema, acute lung injury, pulmonary hemorrhage, and aspiration pneumonia. Filler agents such as talc may result in panacinar emphysema or high-attenuation upper-lobe conglomerate masses. The primary pleural complication of illicit drug use is pneumothorax. Mediastinal and cardiovascular complications of illicit drug use include pneumomediastinum, cardiomyopathy, myocardial infarction, aortic dissection, and injection-related pseudoaneurysms. Chest wall complications include diskitis and vertebral osteomyelitis, epidural abscess, necrotizing fasciitis, costochondritis, and septic arthritis. Categorization of thoracic complications of illicit drug use may facilitate understanding of these disorders and allow accurate diagnosis.

This publication has 38 references indexed in Scilit: